how long have glp 1 drugs been around GLP-1 Receptor Agonist Market Size Frontiers | GLP-1 receptor agonists:
Description
Cost and Insurance Coverage Considerations GLP-1 medication costs vary substantially, and insurance coverage often determines which options are realistically accessible
Due to the metabolic regulatory function of GLP-1RAs, they have also been considered for the treatment of other diseases such as obesity, liver disease and other metabolic dysfunction diseases (22)
It can affect patients both on a psychological and physical level, with overweight and obese people found to be at risk for diabetes, cardiovascular disease, cancer, and premature death [2]
Clin Res Cardiol 2024
Glucagon-like peptide-1 protects against cardiac microvascular injury in diabetes via a cAMP/PKA/Rho-dependent mechanism
Liraglutide was approved in Europe in 2009 and by the FDA in January 2010 as Victoza ( [114] ) ( [115] )
